DiNuzzo Private Wealth
ADMA icon

DiNuzzo Private Wealth’s ADMA Biologics ADMA Stock Holding History

DiNuzzo Private Wealth’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$41 Hold
4
– – ﹤0.01% 1339
2026
Q2 		$34 Sell
4
-13
-76% -$119 ﹤0.01% 1324
2026
Q1 		$154 Sell
17
-6
-26% -$95 ﹤0.01% 1257
2025
Q4 		$420 Buy
23
+2
+10% +$34 ﹤0.01% 1130
2025
Q3 		$363 Sell
21
-11
-34% -$189 ﹤0.01% 1167
2025
Q2 		$583 Buy
32
+4
+14% +$82 ﹤0.01% 1028
2025
Q1 		$556 Hold
28
– – ﹤0.01% 1012
2024
Q4 		$481 Buy
28
+23
+460% +$433 ﹤0.01% 1093
2024
Q3 		$100 Buy
+5
New +$78 ﹤0.01% 1369

Other funds holding ADMA

Marathon Capital Management
Marathon Capital Management Hunt Valley, Maryland $488M AUM 28.5% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Motley Fool Asset Management
Motley Fool Asset Management Alexandria, Virginia $2.64B AUM 26.58% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Empirical Wealth Management
Empirical Wealth Management Seattle, Washington $7.38B AUM 22.9% 1-Year Est. Return
Yousif Capital Management
Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

DiNuzzo Private Wealth's ADMA Position: Q3 2026 in Review

DiNuzzo Private Wealth held its ADMA Biologics (ADMA) position steady in Q3 2026 at 4 shares worth $41. The position accounts for ﹤0.01% of the portfolio, ranked #1339.

DiNuzzo Private Wealth first reported a position in ADMA in Q3 2024 and has held it in 9 quarters since. The position peaked at $583 in Q2 2025. 74 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

  • DiNuzzo Private Wealth held 4 shares of ADMA Biologics worth $41 as of Q3 2026.
  • DiNuzzo Private Wealth left its ADMA Biologics share count unchanged in Q3 2026.
  • ADMA Biologics made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q3 2026, its #1339 holding.
  • DiNuzzo Private Wealth first reported a position in ADMA Biologics in Q3 2024 and has held it in 9 quarters since.
  • DiNuzzo Private Wealth's ADMA Biologics position peaked at $583 in Q2 2025.
  • 74 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.